Summary by Moomoo AI
Caisheng Pharmaceutical Holdings Limited will hold its Annual General Meeting on 28 June 2024 at Shanghai, China. The meeting will discuss a number of agendas, including reviewing the 2023 audited consolidated financial statements and related reports, re-electing board members, and authorizing the Board to determine directors' remuneration. In addition, the meeting will discuss the renewal of PricewaterhouseCoopers as auditor and authorize the Board to determine its remuneration, grant the directors general authority to repurchase and issue shares, and consider amendments to the Articles of Association. Shareholders will exercise voting rights by proxy form and must be submitted by 26 June 2024.